Insulin Aspart: Side Effects, Uses & Monitoring
NovoLog Mix 70/30 is an insulin analog indicated to improve glycemic control in patients with diabetes mellitus.
- Data source
- FDA labeling via NIH DailyMed (label 973a9333…)
- Label version
- current
- Last reviewed
- 2026
Reported adverse reactions
Reactions listed in current FDA labeling, with the highest frequency reported across summarized placebo-controlled trials.
| Adverse reaction (as reported in labeling) | Reported frequency* |
|---|---|
| Hypoglycemia | 76% |
| Headache | 35% |
| Influenza-like symptoms | 13% |
| Rhinitis | 12% |
| Dyspepsia | 9% |
| Neuropathy | 8% |
| Back pain | 7% |
| Diarrhea | 7% |
| Pharyngitis | 7% |
| Skeletal pain | 5% |
| Infection | 5% |
| Abdominal pain | 5% |
*Highest percentage reported for the active moiety across placebo-controlled trial tables in current FDA labeling. Values reflect trial reporting, not your individual risk.
Labeled uses (from FDA prescribing information)
NovoLog Mix 70/30 is an insulin analog indicated to improve glycemic control in patients with diabetes mellitus. Important Limitations of Use: In premix insulins, such as Novolog Mix 70/30, the proportions of rapid acting and long acting insulins are fixed and do not allow for basal versus prandial dose adjustments.
Tests providers may use to monitor Insulin Aspart therapy
Fasting Glucose
Measures blood sugar after fasting to screen for diabetes and prediabetes....
Glucose Blood Test
The glucose test is a blood test used to measure glucose (blood sugar) levels. Glucose is the major source of ...
Hemoglobin A1c (HbA1c)
Reflects average blood sugar over the past 2-3 months....
Frequently Asked Questions
What is Insulin Aspart used for?
FDA labeling lists the approved uses shown above under "Labeled uses." This summary is informational; only a qualified prescriber can determine whether a medication is appropriate for you.
What are the most commonly reported side effects of Insulin Aspart?
The table above shows adverse reactions and the highest frequencies reported in placebo-controlled trials summarized in current FDA labeling for Insulin Aspart. Individual risk varies.
Does Insulin Aspart require lab monitoring?
Labeling and standard practice associate Insulin Aspart with periodic laboratory monitoring; the tests above are commonly ordered by clinicians to monitor patients on therapy. Your provider decides what is appropriate.
Where does this information come from?
All clinical facts on this page were extracted from the current FDA-registered product labeling for this ingredient, published by manufacturers through NIH DailyMed. See the source link below.
Medical disclaimer: Educational content extracted from public FDA labeling. Not medical advice. Always consult a qualified healthcare professional before starting, stopping, or changing any medication.